We found that NZ51 inhibited cell growth of breast cancer cell lines with high DDX3 expression (MCF-7, MDA-MB-468 and MDA-MB-231) but not against two non-cancerous breast cell lines (MCF 10A and MCF 12A) with low DDX3 expression. This evidence concerns the gene DDX3X and breast carcinoma.